S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2020

BVF Partners

Period: Q2 2020 Β· Filed: 2020-08-14
View on SEC EDGAR β†—
AUM
$1.62B
Total portfolio value
Positions
57
Reported securities
Top Holding
SWTX
5.9% $96.0M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2020-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
SWTXSPRINGWORKS THERAPEUTICS INC$96.0M5.92%β€”β€”
5.9%
PRNBPRINCIPIA BIOPHARMA INC$88.8M5.47%β€”β€”
5.5%
ARGXARGENX SE$87.8M5.42%$225.23$939.68+317.2%
5.4%
IONSIONIS PHARMACEUTICALS INC$83.9M5.17%$58.96$81.80+38.7%
5.2%
MRUSMERUS N V$81.9M5.05%β€”β€”
5.0%
XOMAXOMA CORP DEL$79.6M4.91%$19.76$43.00+117.6%
4.9%
ACIUAC IMMUNE SA$76.2M4.70%$6.73$2.51-62.7%
4.7%
XNCRXENCOR INC$67.0M4.13%$32.39$15.00-53.7%
4.1%
RPTXREPARE THERAPEUTICS INC$60.3M3.72%β€”β€”
3.7%
REPLREPLIMUNE GROUP INC$57.5M3.55%$24.85$11.58-53.4%
3.5%
FPRXFIVE PRIME THERAPEUTICS INC$48.7M3.00%β€”β€”
3.0%
RCUSARCUS BIOSCIENCES INC$46.6M2.87%$24.74$30.33+22.6%
2.9%
IDYAIDEAYA BIOSCIENCES INC$45.9M2.83%$14.21$37.65+164.9%
2.8%
KURAKURA ONCOLOGY INC$45.3M2.79%$16.30$11.10-31.9%
2.8%
XENEXENON PHARMACEUTICALS INC$44.1M2.72%$12.54$60.96+386.1%
2.7%
PTGXPROTAGONIST THERAPEUTICS INC$41.8M2.58%$17.66$131.62+645.3%
2.6%
CALACALITHERA BIOSCIENCES INC$37.4M2.31%$105.60$0.00
2.3%
SNDXSYNDAX PHARMACEUTICALS INC$36.6M2.26%$14.82$21.82+47.2%
2.3%
CLDXCELLDEX THERAPEUTICS INC NEW$35.6M2.20%$13.00$38.37+195.2%
2.2%
MTEMXXXXMOLECULAR TEMPLATES INC$29.6M1.83%β€”β€”
1.8%
ANABANAPTYSBIO INC$28.9M1.78%$14.89$63.42+325.9%
1.8%
GLYCGLYCOMIMETICS INC$27.2M1.68%β€”β€”
1.7%
IMVTIMMUNOVANT INC$26.5M1.63%$24.35$38.79+59.3%
1.6%
CTMXCYTOMX THERAPEUTICS INC$25.9M1.60%$8.33$3.82-54.1%
1.6%
RVMDREVOLUTION MEDICINES INC$25.2M1.55%$31.57$189.24+499.4%
1.6%
RNACSELECTA BIOSCIENCES INC$23.6M1.45%$85.20$10.59-87.6%
1.4%
STROSUTRO BIOPHARMA INC$18.4M1.13%$77.60$30.43-60.8%
1.1%
OVIDOVID THERAPEUTICS INC$17.6M1.09%$7.37$2.69-63.5%
1.1%
CALTCALLIDITAS THERAPEUTICS AB$17.5M1.08%β€”β€”
1.1%
MEIPXXXXMEI PHARMA INC$17.1M1.05%β€”β€”
1.1%

Quarter-on-Quarter Activity

Q2 2020 vs. Q1 2020

New Positions (8)

TickerIssuerNotionalSince Filing
RPTXREPARE THERAPEUTICS INC$60.3M
CLDXCELLDEX THERAPEUTICS INC NEW$35.6M+195.2%
CALTCALLIDITAS THERAPEUTICS AB$17.5M
FBRXFORTE BIOSCIENCES INC$14.3M
CFRXCONTRAFECT CORP$10.2M
EVLOEVELO BIOSCIENCES INC$6.4M
CRISCURIS INC$4.4M
EXELEXELIXIS INC$0.4M

Exited Positions (8)

TickerIssuerNotional
CYTKCYTOKINETICS INC$46.4M
MRSNMERSANA THERAPEUTICS INC$13.8M
KZRKEZAR LIFE SCIENCES INC$6.8M
AKROAKERO THERAPEUTICS INC$6.0M
PRVLPREVAIL THERAPEUTICS INC$5.3M
ALPNALPINE IMMUNE SCIENCES INC$3.3M
LKFTGALAPAGOS NV$1.5M
EIGREIGER BIOPHARMACEUTICALS INC$0.5M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
RCUSARCUS BIOSCIENCES INC$46.0M+4780.8%+22.6%
ARGXARGENX SE$84.5M+1460.0%+317.2%
STROSUTRO BIOPHARMA INC$13.5M+398.1%-60.8%
PTGXPROTAGONIST THERAPEUTICS INC$36.9M+241.9%+645.3%
NVUSNOVUS THERAPEUTICS INC$0.6M+160.7%
IDYAIDEAYA BIOSCIENCES INC$40.6M+151.1%+164.9%
RNACSELECTA BIOSCIENCES INC$14.9M+129.8%-87.6%
GMDAQGAMIDA CELL LTD$6.8M+114.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
SNSSSUNESIS PHARMACEUTICALS INC$-1.9M-58.1%
PHATPHATHOM PHARMACEUTICALS INC$-6.9M-52.4%
PIRSPIERIS PHARMACEUTICALS INC$-3.7M-47.0%
RVMDREVOLUTION MEDICINES INC$-5.4M-42.9%+499.4%
FWPAYFORWARD PHARMA A/S$-1.4M-30.1%
IONSIONIS PHARMACEUTICALS INC$-8.1M-26.8%+38.7%
CALACALITHERA BIOSCIENCES INC$-5.0M-25.8%
MTEMXXXXMOLECULAR TEMPLATES INC$-8.2M-24.6%
← Back to Hedge Funds